Answers are grounded in this paper and cite their sources.
Complex regional pain syndrome is a rare but disabling post-traumatic pain condition in which delayed recognition and fragmented care may contribute to chronicity. In 2020, a structured fast-track pathway was implemented at a Swiss tertiary hospital to support recognition, early management, and specialist referral. This retrospective cohort study with a historical control group (pre-pathway: 2015-2019; post-pathway: 2020-2023) included adults referred to an outpatient pain clinic with suspected or confirmed disease. The pathway combined standardised screening, early guideline-based treatment initiated by non-pain specialists, and predefined escalation to specialist pain care. The primary outcome was the time from inciting event to first pain clinic consultation; secondary outcomes included time to first documented clinical features, time to first documented suspicion or diagnosis, and clinician-adjudicated improvement at 12 months. Among 3797 screened records, 179 patients met inclusion criteria (73 pre-pathway, 106 post-pathway). Median time to pain clinic consultation was shorter post-pathway than pre-pathway (165 vs 438 days; P<0.001). At 12 months, 59 of 95 post-pathway patients (62.1%) and 25 of 65 pre-pathway patients (38.5%) were classified as improved (risk difference 23.6%, 95% confidence interval 7.9-37.8; P=0.003). Longer disease duration was associated with lower odds of improvement (adjusted odds ratio per month 0.97, 95% confidence interval 0.95-0.99), with a non-linear association across disease duration. These findings support referral delay as a clinically relevant timing factor in the care of complex regional pain syndrome that health systems can act on. PERSPECTIVE: In this retrospective cohort, a structured fast-track pathway for suspected complex regional pain syndrome was associated with shorter referral latency and higher clinician-adjudicated improvement at 12 months. Longer disease duration was independently associated with lower improvement odds, consistent with a narrowing therapeutic window that health systems can act on.
No takes yet. Share an insight, caveat, or question.
Harnik et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: